相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PRAME Immunohistochemistry as an Ancillary Test for the Assessment of Melanocytic Lesions
Cecilia Lezcano et al.
Surgical Pathology Clinics (2021)
High PRAME expression is associated with poor survival and early disease progression in myelodysplastic syndromes with a low bone marrow blast percentage
Masayuki Shiseki et al.
LEUKEMIA & LYMPHOMA (2021)
Cancer testis antigens in sarcoma: Expression, function and immunotherapeutic application
Ran Wei et al.
CANCER LETTERS (2020)
The role of the cancer testis antigen PRAME in tumorigenesis and immunotherapy in human cancer
Yichi Xu et al.
CELL PROLIFERATION (2020)
Cancer Testis Antigens and Immunotherapy: Expression of PRAME Is Associated with Prognosis in Soft Tissue Sarcoma
Markus Albertsmeier et al.
CANCERS (2020)
Cancer Testis Antigens and Immunotherapy: Where Do We Stand in the Targeting of PRAME?
Ghaneya Al-Khadairi et al.
CANCERS (2019)
Cutaneous T Cell Lymphoma A Difficult Diagnosis Demystified
Erik Peterson et al.
DERMATOLOGIC CLINICS (2019)
The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas
Rein Willemze et al.
BLOOD (2019)
Mycosis fungoides: A great imitator
Emmilia Hodak et al.
CLINICS IN DERMATOLOGY (2019)
Cutaneous T-cell lymphoma (CTCL), rare subtypes: five case presentations and review of the literature
Shamir Geller et al.
CHINESE CLINICAL ONCOLOGY (2019)
Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway
Hanzhang Zhu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
High-throughput sequencing of the T cell receptor β gene identifies aggressive early-stage mycosis fungoides
Adele de Masson et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Mycosis Fungoides and Sezary Syndrome
Francine M. Foss et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2017)
PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma
Gulcin Gezgin et al.
JAMA OPHTHALMOLOGY (2017)
Cutaneous T-cell lymphoma: 2017 update on diagnosis, risk-stratification, and management
Ryan A. Wilcox
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Cutaneous T-cell Lymphoma
Melissa Pulitzer
CLINICS IN LABORATORY MEDICINE (2017)
Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes
Jason Roszik et al.
CLINICAL SARCOMA RESEARCH (2017)
Mycosis Fungoides: A Retrospective Study of 44 Swedish Cases
Yvonne Eklund et al.
ACTA DERMATO-VENEREOLOGICA (2016)
Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers
Arash Salmaninejad et al.
IMMUNOLOGICAL INVESTIGATIONS (2016)
PRAME expression and promoter hypomethylation in epithelial ovarian cancer
Wa Zhang et al.
ONCOTARGET (2016)
PRAME Expression and Its Clinical Relevance in Hodgkin's Lymphoma
Vehbi Ercolak et al.
ACTA HAEMATOLOGICA (2015)
Defining early mycosis fungoides: validation of a diagnostic algorithm proposed by the International Society for Cutaneous Lymphomas
Travis Vandergriff et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2015)
TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCL
Ilan R. Kirsch et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Prognostic significance of PRAME expression based on immunohistochemistry for diffuse large B-cell lymphoma patients treated with R-CHOP therapy
Kenjiro Mitsuhashi et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2014)
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome) Part I. Diagnosis: Clinical and histopathologic features and new molecular and biologic markers
Sarah I. Jawed et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma
L. Dyrskjot et al.
BRITISH JOURNAL OF CANCER (2012)
High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cells
Concetta Quintarelli et al.
BLOOD (2011)
Inhibition of PRAME expression causes cell cycle arrest and apoptosis in leukemic cells
Norina Tanaka et al.
LEUKEMIA RESEARCH (2011)
Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling
Silvia Bea et al.
BLOOD (2009)
PRAME expression and clinical outcome of breast cancer
M. T. Epping et al.
BRITISH JOURNAL OF CANCER (2008)
Tumor associated antigen PRAME is a marker of favorable prognosis in childhood acute myeloid leukemia patients and modifies the expression of S100A4, Hsp 27, p21, IL-8 and IGFBP-2 in vitro and in vivo
Nicolas Tajeddine et al.
LEUKEMIA & LYMPHOMA (2008)
PRAME expression in hairy cell leukemia
Evgeny Arons et al.
LEUKEMIA RESEARCH (2008)
Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
Elise Olsen et al.
BLOOD (2007)
Expression of tumor-associated antigens in acute myeloid leukemia: implications for specific immunotherapeutic approaches
Jochen Greiner et al.
BLOOD (2006)
PRAME is a membrane and cytoplasmic protein aberrantly expressed in chronic lymphocytic leukemia and mantle cell lymphoma
Rodrigo Proto-Siqueira et al.
LEUKEMIA RESEARCH (2006)
Gene expression changes associated with progression and response in chronic myeloid leukemia
JP Radich et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Preferentially expressed antigen of melanoma (PRAME) in the development of diagnostic and therapeutic methods for hematological malignancies
M Matsushita et al.
LEUKEMIA & LYMPHOMA (2003)
PRAME gene expression in childhood acute lymphoblastic leukemia
D Steinbach et al.
CANCER GENETICS AND CYTOGENETICS (2002)
分享论文
